Onyx Biotec Limited (NSE:ONYX)

India flag India · Delayed Price · Currency is INR
33.00
0.00 (0.00%)
At close: Mar 6, 2026
-42.11%
Market Cap 598.36M
Revenue (ttm) 663.87M
Net Income (ttm) 10.68M
Shares Out 18.13M
EPS (ttm) 0.65
PE Ratio 50.93
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,000
Average Volume 10,400
Open 34.00
Previous Close n/a
Day's Range 33.00 - 34.00
52-Week Range 28.10 - 62.45
Beta n/a
RSI 41.34
Earnings Date Feb 12, 2026

About Onyx Biotec

Onyx Biotec Limited develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally. The company offers water for injections (WFI), dry powder injections, and dry powder syrup. It also exports its products. Onyx Biotec Limited was incorporated in 2005 and is based in Chandigarh, India. [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 357
Stock Exchange National Stock Exchange of India
Ticker Symbol ONYX
Full Company Profile

Financial Performance

In fiscal year 2025, Onyx Biotec's revenue was 619.51 million, an increase of 15.26% compared to the previous year's 537.49 million. Earnings were 49.54 million, an increase of 36.31%.

Financial Statements

News

There is no news available yet.